Member Info for Topprize

No surprises in there…

I don’t think a bad thing will be taken more seriously for investors… lining up for the commercialisation news.

This was yesterday… doesn’t it mean the Peer review is completed
St George Street Capital are delighted to announce the publication of our protocol paper in the peer-reviewed journal BMJ Open, which discusses our approach to the ARCADIA clinical trial in COVID19.

Volume already at 280 and not even 8:15!!

Beware drampers folks… all good here!!

Finally we should see a movement towards the recent highs. Hoping for this to be splashed across the news today! GLA

LSE got it wrong again!

Currently 9 variants recorded since the pandemic started.

Covid is mutating all the time.. just because the latest variant has milder symptoms. A newer variant could mutate with more severe symptoms we have yet to see… hopefully not but we just don’t know.

Yep complete bell end with no Bell… can we just not respond to his posts from now on… he is literally a bottom feeder who thrives on peoples misfortune when a sp is falling pure scum of the earth. Just hope karma gives him something to think about. Gla as we still wait. Remember don’t engage with the idiot.

Commercialisation news

Mode launches 0% fees

Emailed them a couple of weeks ago with no response… will try again… what’s annoying is SGS is supposed to fast track new drugs to commercialisation… so frustrating not knowing what is going on. Am sure it’s close as 2 months with getting things in place seems good amount of time, we will see.

Sorry expru jumped in with my response too quickly…

This will deliver and who knows how long the commercialisation deal will take but it will come! What I do know is that we are all p’d off and frustrated big time with waiting and seeing the sp decline on no news!! The times I have had enough and sold up in the past only to regret when it came good. There is NO bad news here we are just tied into AIM market which is rarely predictable when no news.

COVID is still the focus globally at the moment… so will have no problem with commercialisation!

At that price they are sells unfortunately…

If you read the RNS properly

following receipt of the final data from the ARCADIA Phase II clinical trial, SGSC will immediately start to undertake commercial discussions with potential licensees and/or fundraise for further clinical trials to investigate SGS002 ("the Asset") in a larger study. Further analysis to determine the precise nature of the biological effects of the Asset that explain the observed clinical outcomes will also be conducted.

No mention of Phase 3…. Further trials will be done to see what else AZD1656 can be used for!! As mentioned before there is potential that AZD1656 prolongs the effects of the vaccine!! That would be a further trial NOT phase 3… the trial for AZD1656 to be used by diabetic patients with Covid is completed!!

THERE IS NO PHASE 3 TRIAL!!

Looks like another false drop this morning…